tion of blood coagulation by craniotomy would elevate Ddimer plasma levels in a systematic and predictable way in the absence of VTE and that VTE would elevate D-dimer plasma levels beyond this range, implying a threshold with useful values for sensitivity and specificity in postoperative patients.
To our knowledge, this is the first systematic study to evaluate a specific threshold of D-dimer plasma levels for a postoperative patient cohort.
Methods

Patient Population
A single-center prospective study was carried out from April 2010 until February 2012, after approval by the university's ethics committee. Undergoing elective surgery for intracranial pathology via craniotomy and availability of pre-and postoperative Doppler ultrasonography served as the two inclusion criteria. The exclusion criteria were gravidity, age less than 18 years, perioperative administration of blood products, abnormal blood coagulation (thrombocytes and/or plasmatic coagulation factors), administration of antiplatelet agents, preoperative C-reactive protein level greater than 5 mg/L, liver disease, and preoperative detection of DVT. One hundred six consecutive patients met the primary inclusion criteria and gave informed consent.
Five patients were excluded from the study because of preoperatively detected asymptomatic DVT (n = 3) or abnormal preoperative blood coagulation (n = 2; essential thrombocythemia in one case and disturbed thrombocyte function in a platelet-function test in another). Of the remaining 101 patients, 59 were female and 42, male. Their mean age (± SD) was 54 ± 15.4 years (range 18-82 years). Mean BMI was 26.9, and 10 of the 101 patients were smokers. In 61.4% of the patients, the surgically treated pathological condition was supratentorial; in 38.6% it was infratentorial. In 9.9% of the cases, the patients harbored high-grade gliomas (WHO Grade III or IV), and in 5.9%, they had low-grade gliomas. Meningiomas were diagnosed in 33.7% of the 101 patients. Metastasis was seen in 6.9% and vestibular schwannoma in 29.7%. In 5 cases, the patients underwent craniotomy for clip ligation of an incidentally found aneurysm. The remaining patients had cavernomas (n = 2), neurocytomas (n = 2), a hemangioblastoma (n = 1), a dermoid cyst (n = 1), non-Hodgkin lymphoma (n = 1), and trigeminal neuralgia (n = 1). Table 1 summarizes the clinical variables.
All patients were treated with compression stockings from surgical positioning until the 5th postoperative day and received subcutaneously administered LMW-heparin (Certoparin, 3000 IU, once daily) from the 1st postoperative day until discharge. When VTE was diagnosed, therapeutic anticoagulation therapy was instituted, with administration of LMW-heparin twice a day, the dosage depending on the patient's weight and the surgeon's preference.
Doppler Ultrasonography and Diagnosis of PE
All examinations were conducted with the same device (Sonoline Antares, Siemens Sector Healthcare) by Examinations took place on the day before surgery and between the 3rd and 6th days after surgery. Diagnosis of DVT was based on direct thrombus detection by incomplete compressibility of the vessel, observation of lack of blood flow, or both. All anatomical levels of the lowerextremity venous system were thoroughly examined on both sides, including veins of the pelvis (a-sounds). Diagnosed DVTs were subdivided according to consensus terminology 3 into 2 subtypes: 1) proximal DVT, occurring at the level of or craniad to the trifurcation of the popliteal vein, and 2) distal DVT, occurring distal to this level in the deep veins of the lower leg or in muscle veins within the triceps surae.
These subtypes differ significantly regarding incidence and associated risk of PE. 11, 24 Cases of DVT were also classified into symptomatic and asymptomatic subgroups (criteria: tenderness on palpation, swelling, pain).
Pulmonary embolism was diagnosed by CT examination, which was performed if patients had acute dyspnea, unexplained loss of consciousness, thoracic pain, acutely reduced oxygen saturation, resting tachycardia (> 100 bpm), or acutely reduced blood pressure.
D-Dimer Plasma Levels
D-dimer plasma levels were assessed preoperatively and on the 3rd, 7th, and 10th days after surgery with the Siemens Innovance D-dimer test. 5, 8 In an outpatient cohort, sensitivity for this test has been calculated at 99.4% and specificity at 38.2% for a threshold of 0.5 mg/L.
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Statistical Analysis
Statistical analysis was done with IBM SPSS Statistics 19. The mean values of D-dimer plasma levels before surgery and on the 3rd, 7th, and 10th postoperative days were calculated for patients with and without VTE (VTE+ group vs VTE− group). After logarithmic transformation of these values, between-groups comparisons were performed using the Mann-Whitney U-test and Student t-test. For evaluation of discrimination points, an ROC analysis was conducted.
For evaluation of risk factors for VTE, data pertaining to nondichotomous variables were compared by parametric tests only when a gaussian distribution was confirmed (P-P plots, histograms, Kolmogorov-Smirnov test); otherwise, nonparametric testing was used. For dichotomous variables, the Fisher exact test was used.
Results were deemed significant with p < 0.05 and highly significant with p < 0.001 (based on 2-tailed tests). The Bonferroni method was used to correct for multiple comparisons.
Results
Postoperative VTE was diagnosed in 42.6% of all patients. Deep venous thrombosis was seen in 39.6% (isolated distal DVT in 25.7%; proximal DVT, which was always combined with distal DVT, in 13.9%). Of 40 diagnosed cases of DVT, 9 were symptomatic (representing 22.5% of the patients with DVT, 8.9% of all patients). Symptomatic PE was detected in 8.9% of the patients.
Risk Factors for VTE
Various clinical variables were assessed and analyzed for their potential impact regarding incidence of VTE (Table 1) . A highly significant difference (p < 0.001) was demonstrated exclusively for duration of surgery and for ventilation time. In patients without VTE, the mean duration of surgery was 255 minutes, whereas it was 363 minutes in patients with VTE. The mean ventilation time was 359 minutes in patients without VTE and 473 minutes in patients with VTE. After Bonferroni correction, significance with p < 0.001 was retained for both variables.
Trepanation in the occipitoparietal region seemed to be associated with a reduced risk for VTE (p = 0.041). However, statistical significance was not retained after Bonferroni correction. Also, patients undergoing this kind of trepanation were observed to have a shorter mean duration of surgery (171 minutes vs 363 minutes).
Postoperative bleeding necessitating surgical evacuation was seen in 2 patients (2%). Both were in the VTE+ group. In one case, bleeding took place before the first administration of prophylactic LMW-heparin; in the other patient, the bleeding was observed under therapeutic anticoagulation. There was no statistically significant difference between the VTE+ and VTE− groups with respect to incidence of postoperative bleeding.
D-Dimer Plasma Level: Comparison of Mean Values
Regarding D-dimer plasma level values, the Kolmogorov-Smirnov test excluded a gaussian distribution of the data (KS-Z 1.598, p = 0.012). Consequently, the data were logarithmically transformed for parametric testing in addition to nonparametric testing (KS-Z after transformation 0.541, p = 0.931).
Comparison of mean D-dimer plasma levels in the VTE− group and VTE+ group was performed for values obtained preoperatively and on the 3rd, 7th, and 10th postoperative days. Highly significant differences were ob served on the 3rd, 7th, and 10th postoperative days (p < 0.001 each), but not preoperatively (p = 0.195) (Fig.  1) . Likewise, the nonparametric Mann-Whitney U-test showed highly significant between-groups differences (p < 0.001) for all postoperative measurements, but no significant difference (p = 0.531) in the preoperative mean values (Table 2) .
Preoperatively, the mean D-dimer plasma level was 0.62 mg/L in the patients who did not develop VTE (VTE− group) and 0.74 mg/L in those who did (VTE+ group). On the 3rd day after surgery it was 1.59 mg/L in the VTE− group and 5.49 mg/L in the VTE+ group. This difference decreased over time; on the 7th day, the D-dimer plasma level was 1.29 mg/L in the VTE− group and 3.8 mg/L in the VTE+ group, and on the 10th day it was 1.11 mg/L in the VTE− group and 2.26 mg/L in the VTE+ group (Fig. 1) .
In patients in the VTE− group, D-dimer plasma levels were found to be in a homogeneous range, with stable standard deviations, over the whole time course. An initial rise of the mean value from 0.62 mg/L preoperatively to 1.59 mg/L on the 3rd postoperative day was observed, followed by decline to 1.29 mg/L on the 7th day and 1.11 mg/L on the 10th day ( Fig. 1 and Table 2 ).
Determination of Discrimination Points: D-Dimer Plasma Level Thresholds
Discrimination points were evaluated for D-dimer plasma levels only on the 3rd postoperative day, as the levels on the 7th and 10th days were assessed under conditions of therapeutic anticoagulation in patients with VTE. This was unavoidable for ethical reasons.
An ROC analysis was used to evaluate D-dimer plasma levels on the 3rd day after surgery with regard to the presence or absence of VTE. The AUC was calculated to be 0.92 with p < 0.001, a standard error of 0.03, an asymp totic confidence interval (95%) ranging from 0.861 to 0.979. The ROC curve rose vertically, with 100% specificity, and started to deviate toward lower specificity only after 55% sensitivity was reached (Fig. 2) .
In addition to the standard cut-off value (0.5 mg/L), 4 additional cut-off values were evaluated. Their characteristics were as follows: 1) optimum sensitivity for VTE, 2) optimum specificity for VTE, 3) optimum balanced sensitivity/specificity (Youden index For optimum sensitivity (100%), a cut-off value of 0.86 mg/L was identified, providing 20.7% specificity for VTE with an NPV of 100% and a PPV of 48.3% (Fig. 2) .
A threshold of 4.3 mg/L provided optimum specificity (100%) for VTE with a sensitivity of 55.8%, an NPV of 75%, and a PPV of 100% (Fig. 2) .
The Youden index (J) reaches its maximum value for the specific discrimination point in the ROC curve with maximum distance to the diagonal reference line and optimizes the discriminatory power of a test, assuming that sensitivity and specificity are of the same value. Thus, a cut-off value of 3.3 mg/L was calculated (J = 0.72). The sensitivity was 79.1% and the specificity 93.1%. The NPV was 85.7% and the PPV 89.5% (Fig. 2) .
Based on the data, a specific cut-off value excluding almost all of the patients in the VTE+ group (with the exception of 2 outliers) was defined to provide a threshold emphasizing clinical applicability (Fig. 1) . The threshold was rounded and set to 2 mg/L. With this threshold, the sensitivity for VTE was 95.3% and the specificity was 74.1%; the NPV was 95.6%, and the PPV 73.2%. In one of the 2 excluded outliers, isolated distal DVT was seen (D-dimer plasma level 0.91 mg/L on the 3rd day), and in the other patient we diagnosed combined proximal/distal DVT with a D-dimer level of 0.86 mg/L (Figs. 1 and 2 ). With the standard values applied (0.5 mg/L), the sensitivity was found to be 100%; the specificity, however, was very low, 6.9%. The NPV was 100%, but the PPV was only 44.3% (Fig. 2) .
VTE Subtype and D-Dimer Plasma Levels
More extensive VTE was associated with higher Ddimer plasma levels (Fig. 3) . For patients without VTE, the mean D-dimer plasma level on the 3rd day after surgery was 1.59 mg/L (range 0.17-4.3 mg/L, SD 0.98 mg/L). Patients with isolated distal DVT had a mean of 4.56 mg/L (range 0.92-10.21 mg/L, SD 2.12 mg/L). In patients with combined proximal and distal DVT, the mean value was 6.36 mg/L (range 0.86-12.41 mg/L, SD 4.14 mg/L). In patients with symptomatic PE (n = 9), the highest mean D-dimer plasma level was observed: 7.14 mg/L (range 4.11-13.33 mg/L, SD 3.56 mg/L) ( Table 3) . On the 3rd postoperative day, D-dimer plasma levels differed in a statistically significant way between patients with diagnosed PE on one side of the spectrum and patients with isolated distal DVT on the other side (p = 0.045 after Bonferroni correction for multiple testing) ( Table 4) .
Discussion
The data from this study support the hypothesis that undergoing elective craniotomy raises D-dimer plasma levels in a predictable way, while VTE leads to significantly higher values. Postoperative D-dimer plasma levels were almost universally elevated beyond the standard threshold of 0.5 mg/L, 8 slowly declining over time during the postoperative period. In patients with VTE, the levels were found to be significantly higher than in those without VTE (p < 0.001).
The development of VTE was not influenced by patient age, Karnofsky Performance Status score, sex, status as a smoker or nonsmoker, the specific pathological condition present and its localization, the extent of the trepanation, raised preoperative D-dimer levels, or BMI. This finding partially contradicts other studies, 15 which have demonstrated a higher risk for VTE in patients with malignancy and older age; the contradiction may be due to the sample size of 101 patients in the present study. However, longer duration of surgery and longer ventilation time proved to be risk factors for the development of VTE in concordance with other studies. 17 In outpatients, D-dimer testing is usually employed only when clinical signs of VTE are present, but prevalence of DVT even in suspected cases has been reported to be only 19.8% in meta-analysis. 26 Circumstances are, however, quite different in a postoperative cohort with a high incidence of newly acquired DVT (42.6%) as presented in our study. This is especially true since DVT is believed to be the source of 90% of all PEs, 7 and embo- * VTE subtypes: 0 = no VTE; 1 = isolated distal DVT; 2 = combined proximal and distal DVT; 3 = PE. lism proves lethal in up to 50% of cases. 13, 17 Pulmonary embolism has been observed in 3.7% of all patients undergoing neurosurgery in a prospective series. 15 In the present study, symptomatic PE was diagnosed even in 8.9% of all patients. The routine use of serial sonography for all postoperative patients warrants consideration. Failing this, there is a need for an effective screening method, as shown by the above numbers.
A highly significant deviation from the ROC null hypothesis was found in evaluation of D-dimer plasma levels as a marker for the presence/absence of postoperative VTE. The AUC for our overall group on the 3rd day after surgery was 0.92; this is comparable to findings in outpatients (AUC 0.9). 8 Thus, the definition of a clinically applicable threshold becomes a conceivable goal.
Based on our data, we propose D-dimer screening with a threshold of 2 mg/L. With this cut-off value, which in cluded all cases other than the 2 statistical outliers (Fig. 1) , sensitivity is somewhat lower (95.3% vs 99.4%), while specificity is clearly higher (74.1% vs 38.2%) than is achieved when the standard value of 0.5 mg/L is applied to outpatients. The value of 2 mg/L appears to be a robust threshold; the great majority of patients with diagnosed VTE presented with D-dimer plasma levels greater than 3 mg/L on the 3rd postoperative day (Fig. 1) . This value has the potential to be a reliable cut-off value for postoperative screening in neurosurgical patients. In only 1 of 4 patients would the thus-induced additional diagnostic evaluations yield negative results (PPV 73.2%).
In 95.6% (NPV) of all patients with D-dimer plasma levels lower than 2 mg/L, no VTE was present on the 3rd day after surgery, implying that 1 of 20 patients would be at risk for undiagnosed VTE. While not perfect, this test appears to be significantly better than clinical suspicion as the sole "screening" method. In our study group, 8.9% of all patients presented with clinically apparent DVT. This percentage is comparatively high but is still within the same general magnitude as values found in the literature for patients harboring intracranial tumors (2.3%-7.5%); 4, 29 the relatively high percentage might be partially explained by the raised vigilance for DVT as the prospective study was conducted. However, the general incidence of DVT (39.6%) was more than 4 times higher than the incidence of symptomatic DVT (8.9%). Given these proportions, more than 3 of 4 patients with DVT would remain undiagnosed and at risk without D-dimer screening.
The high incidence of VTE found in the present study stresses the perception of the neurosurgical patient as a high-risk patient with respect to this condition. As a consequence, the prevention of VTE deserves more attention. Intermittent pneumatic compression might be of value. Given that ventilation time and duration of surgery were the only identifiable risk factors for postoperative VTE with p < 0.001 each, it appears that DVT develops during surgery itself in the majority of patients. Consequently, intermittent pneumatic compression may be most efficient when started intraoperatively.
The majority of patients with VTE in the present study harbored (mostly asymptomatic) distal DVT. The 9th edition of the American College of Chest Physicians (ACCP) guidelines on antithrombotic therapy and prevention (http://journal.publications.chestnet.org/issue.aspx? journalid=99&issueid=23443&direction=P) recommends follow-up ultrasonography in patients with isolated distal DVT or initial treatment with anticoagulant agents if risk factors are present. According to the guidelines, active cancer and hospitalized status are believed to be among these risk factors. The recommendations are based primarily on natural history studies, which show that distal DVT may progress and affect more proximal venous structures in up to 15% of cases and that this is most likely to occur during the first 2 weeks after surgery. 16, 20, 21, 23 The incidence of symptomatic PE due to DVT in muscle veins was reported to be 7%, and the rate of recanalization in patients treated with therapeutic anticoagulation has been given as 85%. 12 Given all these observations and recommendations, many centers will treat distal DVT despite its comparatively low risk of complications, as the fear of the complications associated with DVT outweighs the fear of complications associated with anticoagulation. With respect to the data presented, it seems that therapeutic anticoagulation is surprisingly safe even in a high-risk population of patients who have very recently undergone brain surgery. Two instances of postoperative bleeding were observed. Although both patients were in the VTE+ group, the bleeding was potentially associated with therapeutic anticoagulation in only one of them (in the other patient, the bleeding took place even before administration of the first prophylactic LMW-heparin dose).
Conclusions
Using a threshold of 2 mg/L, D-dimer levels will indicate VTE in patients after craniotomy with high sensitivity and specificity. Pulmonary embolism seems to be indicated by even higher D-dimer levels. Ventilation time and duration of surgery are highly significant risk factors for the development of VTE; other clinical factors, such as tumor entity and the extent of operative trauma, do not seem to play a key role in this respect.
The present study was conducted in a strictly neurosurgical patient group after elective craniotomy. We are, however, convinced that our results are, in principle, transferable to any reasonably homogeneous postoperative patient population. Future studies are needed to determine the respective D-dimer threshold for these patient groups.
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